With the breakthroughs in synthetic biology and system biology, de novo synthesized DNA and RNA molecules or variant libraries are widely used in pharmaceutical, agriculture, biofuel and biological/chemical production. As our understanding of DNA sequences (Genotype) and biological functions (Phenotype) increases, the ability to design and synthesize (Synotype) genes, genomes, pathways, and organisms by using synthetic biology techniques is also improving quickly. Synbio Tech. has created the comprehensive Synotype platforms for biological researchers that dedicate to integrating the cutting edge synthetic biology techniques and bio-informatic tools into an advanced biological innovation platform.
Synbio Technologies’ Synotype platform was conceived, designed and implemented with synthetic biology technology to produce:
1. A novel approach to deepen our knowledge on genotying (reading by writing);
2. A simple approach to characterize phenotyping (understanding by writing);
3. A quick approach to study the correlations of genotyping and phenotyping (linking by writing);
4. A cost effective approach to design and produce the novel sequence and subsequent function traits (creating by writing).
In addition, Synbio Tech. is building up the first integrated GPS (Genotype, Phenotype and Synotype) system aimed to a quick and easy translation or reverse translation between “Genotype” and “Phenotype” by using our proprietary “Synotype” platform.
The company’s scientific capabilities encompass areas such as DNA engineering, DNA synthesis, genome synthesis, pathway synthesis, synthetic biology, pharmacogenomics, microbiology, translational biology and the applications of synthetic biology. Synbio Technologies’ team has a proven track record regarding translating scientific breakthroughs into cost effective biological solution.
Synbio Technologies LLC
1 Deer Park Drive, Suite L-1
Tel: +1 732-230-3003
Fax: +1 609 228 5911
Building C20, Biobay,
218 Xinghu Street,
SIP, Suzhou, 215123
Tel: +86-512-6260 0336
Fax: +86-512-6260 0337